Ohio Right to Life Statement on Abortion Pill Reversal Study
FOR IMMEDIATE RELEASE CONTACT: Stephanie Ranade Krider
DATE: Friday, December 6, 2019 PHONE: 614-547-0099 ext. 302
COLUMBUS, Ohio– A questionable study that involved performing multiple abortions on pregnant women was ended at UC Davis recently.
“Additionally, to assign the adverse effects experienced by their patients to progesterone [as the study’s author’s have done in their public statements], a drug commonly prescribed to prevent miscarriage and preterm labor, is to willfully ignore the facts at hand. Two of the three women cited who experienced heavy bleeding did not even receive progesterone- they received only mifepristone, which is already recognized by the FDA to cause ‘severe bleeding’ that may require hospitalization.”
“Twenty four women have died after taking the mifeprex regimen, while no deaths have ever been reported as a result of progesterone. The abortion industry has no incentive to promote information that may save the life of the baby they have tried to end, which is why Senate Bill 155, the Abortion Pill Reversal Information Act, is so crucial to getting information into the hands of women who need it.”
Founded in 1967, Ohio Right to Life, with more than 45 chapters and local affiliates, is Ohio’s oldest and largest grassroots pro-life organization. Recognized as the flagship of the pro-life movement in Ohio, ORTL works through legislation and education to promote and defend innocent human life from conception to natural death.